Table 1 Main study cohort characteristics (n = 75) at week 2 unless otherwise stated
Study Population | |
|---|---|
Age (mean, SE) | 69.4 (1.2) |
Gender (n, % male) | 48 (66.7) |
Cause of ESKD (n, %) | |
DM | 31 (41.3) |
GN | 23 (30.6) |
Diabetes (n, %) | 39 (52.0) |
Dialysis Vintage (months, SE) | 61.8 (6.3) |
Dialysis duration (min, 95% SE) | 269.2 (2.8) |
Dialysis Access (n, %) | |
AVF | 67 (89.3) |
AVG | 5 (6.7) |
Serum FGF-23 (mean RU/ml, SE) | |
Week 1 | 1615.5 (396.4) |
Week 2 | 1390.5 (318.0) |
Week 3 | 1564.6 (376.7) |
Phosphate (mean mmol/L, SE) | |
Week 1 | 1.45 (0.05) |
Week 2 | 1.46 (0.04) |
Week 3 | 1.49 (0.05) |
25(OH)D (mean nmol/L, SE) | 70.7 (4.1) |
PTH (mean pmol/L, SE) | 32.6 (3.2) |
Calcium (mean mmol/L, SE) | 2.20 (0.02) |
ALP (mean mmol/L, SE) | 142.1 (10.1) |
Cinacalcet (n, %) | 26 (34.6) |
Calcitriol (n, %) | 43 (57.3) |
Phosphate binders (n, %) | 69 (92.0) |